Previous 10 |
REDWOOD CITY, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced that Elisabeth Sandoval has been appointed as a member of M...
Menlo Therapeutics ( MNLO ) is emerging from one of the wildest rides that any stock could ever have, after it plunged massively in October 2018 from its $12 highs. 2019 has opened on a very good note for this stock as the price has moved firmly upwards from its 2018 lows. Now that the stock i...
REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced that management will present at the 31 st Annual ROTH Conf...
Menlo Therapeutics (NASDAQ: MNLO ): Q4 GAAP EPS of -$0.76. More news on: Menlo Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
REDWOOD CITY, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced financial results for the fourth quarter and year ended Dece...
REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced that an abstract has been accepted for oral presentation at ...
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Incyte Corporation (NASDAQ:INCY), Burlington Stores, Inc. (NYSE:BURL), Ha...
Gainers: PI +41% . GNC +27% . TLRY +18% . PDD +17% . MNLO +14% . ABAC +14% . HMHC +14% . LEJU +13% . CKPT +13% . EVRI +13% . More news on: Impinj, Inc., GNC Holdings, Inc., Tilray, Inc., Stocks on the move, , Read more ...
NEW YORK, Aug. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SpartanNash Company (NASDAQ:SPTN), Encana Corporation (NYSE:ECA), Hilltop...
News, Short Squeeze, Breakout and More Instantly...
BRIDGEWATER, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the upcoming H.C. Wainwright 22 nd Annual Global Investment Confe...
BRIDGEWATER, N.J. , Sept. 8, 2020 /PRNewswire/ -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today completed its previously announced corporate name change from Menlo Therapeutics Inc. to VYNE Therapeutics Inc. and the change of its ticker symbol from "MNLO" to "...
Company will commence trading under new ticker “VYNE” on September 8, 2020 Company to ring Nasdaq Closing Bell on September 8 BRIDGEWATER, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”...